comparemela.com

Page 2 - Franck Mouthon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AISTROSIGHT: NEW JOINT PROJECT TEAM BETWEEN THERANEXUS, INRIA, CLAUDE BERNARD UNIVERSITY LYON 1 AND HOSPICES CIVILS DE LYON TARGETING RARE NEUROLOGICAL DISEASES

Lyon, France - 10 February 2023 - 7.30am CET - Theranexus, Inria, Claude Bernard University Lyon 1 and Hospices Civils de Lyon today announced the launch of the new public-private project team "AlstroSight".

France generalThomas lacondemineBruno sportisseClaude bernard lyonSchwierige zeitenLaurence goussuRaymond le moignThierry lambertFlorence portejoieMartin pierre laurentFranck mouthonMinistry of higher educationHealth acceleration strategyClaude bernard university lyonMinistry of healthAtomic energy commission

THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2022 AND ANNOUNCES ORGANIZATIONAL CHANGES

Lyon, France - 18 January 2023 - 7.30am CET - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating

France generalThierry lambertInserm transfertMathieu charvFranck mouthon mathieuFlorence portejoieMartin pierre laurentFrench national institute of healthAtomic energy commissionResearch insermFranck mouthonTheranexus executive chairmanFrench national instituteMedical researchFrench alternative energiesEuronext growth

THERANEXUS AND INSERM TRANSFERT SIGN A STRATEGIC ALLIANCE TO IDENTIFY ADVANCED THERAPY DRUG CANDIDATES FOR RARE NEUROLOGICAL DISEASES

Lyon, Paris, France - 20th October 2022 - 6 pm CEST - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates

France generalHaute normandieInserm transfertFranck mouthonEuropean institute of chemistryInserm transfert initiativeUniversity of bordeauxFrench national institute of healthAtomic energy commissionResearch insermFrench national instituteMedical researchNucleic acidsArtificial regulationsEuropean institutePascale aug

THERANEXUS: THERANEXUS ANNOUNCES ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2022

Lyon, France - 27 September 2022 - 6pm CEST - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating

France generalThierry lambertFlorence portejoieMartin pierre laurentFranck mouthonResearch tax creditAtomic energy commissionIris capitalFrench alternative energiesEuronext growth

THERANEXUS: Theranexus and BBDF finalize recruitment for phase I/II trial to evaluate Batten-1 in Batten disease

Lyon, France - Austin, Texas, United States - 8 September 2022 - 6 pm CEST - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development

United statesFrance generalGary clarkCraig bensonThierry lambertFlorence portejoieMartin pierre laurentFranck mouthonNational organization for rare disordersAtomic energy commissionBatten disease foundationBeyond batten disease foundationChild neurologyTexas childrenFrench alternative energiesEuronext growth

vimarsana © 2020. All Rights Reserved.